ISPOR - PCN22 Real-World Effectiveness of Eribulin in the Patients with Metastatic Breast Cancer: Evidence from Single Medication Center in Taiwan

Full Text

PCN22 Real-World Effectiveness of Eribulin in the Patients with Metastatic Breast Cancer: Evidence from Single Medication Center in Taiwan

Abstract

Authors

K.C. Chang Y.H. Lee

Back to Volume 23, Supplemental S2

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now